Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net)

Casper Webers, Esther Beckers, Annelies Boonen, Yvonne Van Eijk-Hustings, Harald Vonkeman, Mart Van De Laar, Astrid Van Tubergen

Research output: Contribution to journalArticleAcademicpeer-review

3 Downloads (Pure)

Abstract

Objective To develop and test the usability and acceptability of a disease-specific integrated electronic health (eHealth) system for spondyloarthritis (SpA) in the Netherlands ('SpA-Net'). Methods SpA-Net was developed in four phases. First, content and design were discussed with experts on SpA and patients. Second, the database, electronic medical record (EMR) and quality management system were developed. Third, multiple rounds of testing were performed. Fourth, the eHealth system was implemented in practice and feasibility was tested among patients through semistructured focus interviews (n=16 patients) and among care providers through feedback meetings (n=11 rheumatologists/fellows and 5 nurses). Results After completion of the first three steps of development in 2015, SpA-Net was implemented in 2016. All patients included have a clinical diagnosis of SpA. Information on domains relevant to clinical record-keeping is prospectively collected at routine outpatient consultations and readily available to care providers, presented in a clear dashboard. Patients complete online questionnaires prior to outpatient visits. In February 2019, 1069 patients were enrolled (mean [SD] age 54.9 [14.1] years, 52.4% men). Patients interviewed (n=16) considered SpA-Net an accessible system that was beneficial to disease insight and patient-physician communication, and had additional value to current care. Care providers appreciated the additional information for (preparing) consultations. Barriers were the initial time required to adopt the EMR and the quantity of data entry. Conclusion SpA-Net enables monitoring of patients with SpA and real-life data collection, and could help improve knowledge and optimise communication between patients and care providers. Both considered SpA-Net a valuable addition to current care. Trial registration number NTR6740.

Original languageEnglish
Article numbere000860
JournalRMD Open
Volume5
Issue number1
DOIs
Publication statusPublished - 11 Apr 2019

Fingerprint

Netherlands
Health
Electronic Health Records
Patient Care
Outpatients
Referral and Consultation
Communication
Forms and Records Control
Physiologic Monitoring
Nurses
Databases
Interviews
Physicians

Keywords

  • ehealth
  • quality of care
  • quality registry
  • spondyloarthritis

Cite this

Webers, Casper ; Beckers, Esther ; Boonen, Annelies ; Van Eijk-Hustings, Yvonne ; Vonkeman, Harald ; Van De Laar, Mart ; Van Tubergen, Astrid. / Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net). In: RMD Open. 2019 ; Vol. 5, No. 1.
@article{d4418e5d9f814d68818c3408a0b7d4e3,
title = "Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net)",
abstract = "Objective To develop and test the usability and acceptability of a disease-specific integrated electronic health (eHealth) system for spondyloarthritis (SpA) in the Netherlands ('SpA-Net'). Methods SpA-Net was developed in four phases. First, content and design were discussed with experts on SpA and patients. Second, the database, electronic medical record (EMR) and quality management system were developed. Third, multiple rounds of testing were performed. Fourth, the eHealth system was implemented in practice and feasibility was tested among patients through semistructured focus interviews (n=16 patients) and among care providers through feedback meetings (n=11 rheumatologists/fellows and 5 nurses). Results After completion of the first three steps of development in 2015, SpA-Net was implemented in 2016. All patients included have a clinical diagnosis of SpA. Information on domains relevant to clinical record-keeping is prospectively collected at routine outpatient consultations and readily available to care providers, presented in a clear dashboard. Patients complete online questionnaires prior to outpatient visits. In February 2019, 1069 patients were enrolled (mean [SD] age 54.9 [14.1] years, 52.4{\%} men). Patients interviewed (n=16) considered SpA-Net an accessible system that was beneficial to disease insight and patient-physician communication, and had additional value to current care. Care providers appreciated the additional information for (preparing) consultations. Barriers were the initial time required to adopt the EMR and the quantity of data entry. Conclusion SpA-Net enables monitoring of patients with SpA and real-life data collection, and could help improve knowledge and optimise communication between patients and care providers. Both considered SpA-Net a valuable addition to current care. Trial registration number NTR6740.",
keywords = "ehealth, quality of care, quality registry, spondyloarthritis",
author = "Casper Webers and Esther Beckers and Annelies Boonen and {Van Eijk-Hustings}, Yvonne and Harald Vonkeman and {Van De Laar}, Mart and {Van Tubergen}, Astrid",
year = "2019",
month = "4",
day = "11",
doi = "10.1136/rmdopen-2018-000860",
language = "English",
volume = "5",
journal = "RMD Open",
issn = "2056-5933",
publisher = "BMJ Publishing Group",
number = "1",

}

Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net). / Webers, Casper; Beckers, Esther; Boonen, Annelies; Van Eijk-Hustings, Yvonne; Vonkeman, Harald; Van De Laar, Mart; Van Tubergen, Astrid.

In: RMD Open, Vol. 5, No. 1, e000860, 11.04.2019.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net)

AU - Webers, Casper

AU - Beckers, Esther

AU - Boonen, Annelies

AU - Van Eijk-Hustings, Yvonne

AU - Vonkeman, Harald

AU - Van De Laar, Mart

AU - Van Tubergen, Astrid

PY - 2019/4/11

Y1 - 2019/4/11

N2 - Objective To develop and test the usability and acceptability of a disease-specific integrated electronic health (eHealth) system for spondyloarthritis (SpA) in the Netherlands ('SpA-Net'). Methods SpA-Net was developed in four phases. First, content and design were discussed with experts on SpA and patients. Second, the database, electronic medical record (EMR) and quality management system were developed. Third, multiple rounds of testing were performed. Fourth, the eHealth system was implemented in practice and feasibility was tested among patients through semistructured focus interviews (n=16 patients) and among care providers through feedback meetings (n=11 rheumatologists/fellows and 5 nurses). Results After completion of the first three steps of development in 2015, SpA-Net was implemented in 2016. All patients included have a clinical diagnosis of SpA. Information on domains relevant to clinical record-keeping is prospectively collected at routine outpatient consultations and readily available to care providers, presented in a clear dashboard. Patients complete online questionnaires prior to outpatient visits. In February 2019, 1069 patients were enrolled (mean [SD] age 54.9 [14.1] years, 52.4% men). Patients interviewed (n=16) considered SpA-Net an accessible system that was beneficial to disease insight and patient-physician communication, and had additional value to current care. Care providers appreciated the additional information for (preparing) consultations. Barriers were the initial time required to adopt the EMR and the quantity of data entry. Conclusion SpA-Net enables monitoring of patients with SpA and real-life data collection, and could help improve knowledge and optimise communication between patients and care providers. Both considered SpA-Net a valuable addition to current care. Trial registration number NTR6740.

AB - Objective To develop and test the usability and acceptability of a disease-specific integrated electronic health (eHealth) system for spondyloarthritis (SpA) in the Netherlands ('SpA-Net'). Methods SpA-Net was developed in four phases. First, content and design were discussed with experts on SpA and patients. Second, the database, electronic medical record (EMR) and quality management system were developed. Third, multiple rounds of testing were performed. Fourth, the eHealth system was implemented in practice and feasibility was tested among patients through semistructured focus interviews (n=16 patients) and among care providers through feedback meetings (n=11 rheumatologists/fellows and 5 nurses). Results After completion of the first three steps of development in 2015, SpA-Net was implemented in 2016. All patients included have a clinical diagnosis of SpA. Information on domains relevant to clinical record-keeping is prospectively collected at routine outpatient consultations and readily available to care providers, presented in a clear dashboard. Patients complete online questionnaires prior to outpatient visits. In February 2019, 1069 patients were enrolled (mean [SD] age 54.9 [14.1] years, 52.4% men). Patients interviewed (n=16) considered SpA-Net an accessible system that was beneficial to disease insight and patient-physician communication, and had additional value to current care. Care providers appreciated the additional information for (preparing) consultations. Barriers were the initial time required to adopt the EMR and the quantity of data entry. Conclusion SpA-Net enables monitoring of patients with SpA and real-life data collection, and could help improve knowledge and optimise communication between patients and care providers. Both considered SpA-Net a valuable addition to current care. Trial registration number NTR6740.

KW - ehealth

KW - quality of care

KW - quality registry

KW - spondyloarthritis

UR - http://www.scopus.com/inward/record.url?scp=85064972947&partnerID=8YFLogxK

U2 - 10.1136/rmdopen-2018-000860

DO - 10.1136/rmdopen-2018-000860

M3 - Article

VL - 5

JO - RMD Open

JF - RMD Open

SN - 2056-5933

IS - 1

M1 - e000860

ER -